Female sex hormones inversely regulate acute kidney disease susceptibility throughout life
While epidemiological and experimental studies have demonstrated kidney-protective effects of estrogen and female sex in adulthood, some epidemiological data showed deterioration of kidney function during puberty when estrogen production increases. However, molecular mechanisms explaining these conflicting phenomena remain unknown. Here, we showed that the pubertal sex hormone surge in female mice increases susceptibility to kidney ischemia reperfusion injury partly via downregulation of insulin-like growth factor 1 receptor (IGF-1R) expression in proximal tubules. Adult mice ovariectomized pre-pubertally (at postnatal day 21) showed strong tolerance to kidney ischemia, which was partly reversed by the administration of 17β-estradiol, while adult mice ovariectomized post-pubertally (at 8 weeks of age) were vulnerable to kidney ischemia. Kidney tubular IGF-1R protein expression decreased during postnatal growth but was highly expressed in adult mice ovariectomized pre-pubertally and in infant mice, which might be partly explained by different expression of an E3 ligase (MDM2) of IGF-1R. Mice deficient of Igf-1r in proximal tubules (iIGF-1RKO mice) during postnatal kidney growth showed increased susceptibility to ischemic injury. RNA-seq and western blotting analysis using proximal tubular cells from pre-pubertally ovariectomized iIGF-1RKO and control mice revealed altered expression of cell cycle-associated molecules such as cyclin D1. These results suggest that Igf-1r deletion during postnatal growth renders proximal tubular cells susceptible to ischemia possibly via altered cell cycle regulation. Thus, our findings provide evidence that exposure to pubertal sex hormones leads to increased susceptibility to kidney ischemia, which is partly mediated by modulation of IGF-1R signaling.
Authors
- Naoya Toriu (ORCID: https://orcid.org/0000-0002-3712-6331)
- Keisuke Taniguchi (ORCID: https://orcid.org/0000-0002-3328-7808)
- Yoshiki Sahara
- Naoto Kubota (ORCID: https://orcid.org/0000-0002-1849-5078)
- Yoko Shimizu (ORCID: https://orcid.org/0000-0002-8979-2686)
- Sonoko Kinjo (ORCID: https://orcid.org/0000-0003-3403-8923)
- Ryo Yamada (ORCID: https://orcid.org/0000-0002-1587-630X)
- Eiichiro Uchino (ORCID: https://orcid.org/0000-0002-3148-0858)
- Minoru Takasato (ORCID: https://orcid.org/0000-0002-0458-7414)
- Hironori Haga (ORCID: https://orcid.org/0000-0003-4322-9561)
- Takayoshi Sasako (ORCID: https://orcid.org/0000-0002-7644-309X)
- Yuki Sato (ORCID: https://orcid.org/0000-0002-9209-2437)
- Takashi Kadowaki (ORCID: https://orcid.org/0000-0002-5428-3582)
- Yasuhiro Murakawa
- Akiko Oguchi (ORCID: https://orcid.org/0000-0002-9948-6295)
- Motoko Yanagita (ORCID: https://orcid.org/0000-0002-0339-9008)
- Shingo Fukuma (ORCID: https://orcid.org/0000-0002-8379-8761)
- Yuichiro Kitai
- Takahisa Yoshikawa (ORCID: https://orcid.org/0000-0003-3426-5982)
- Hiroyuki Arai
- Makiko Kondo
Institutions
- National Institute of Genetics (JP)
- Kyoto University (JP)
- University of Tokyo Hospital (JP)
- RIKEN Center for Biosystems Dynamics Research (JP)
- Kyoto University Hospital (JP)
- RIKEN Center for Integrative Medical Sciences (JP)
- Toranomon Hospital (JP)
- The University of Tokyo (JP)
Publication Details
- Journal
- Kidney International
- Published
- 2024-11-05
- DOI
- https://doi.org/10.1016/j.kint.2024.08.034
- Citations
- 8
- Primary Topic
- Pregnancy and Medication Impact
- Type
- article
- Field-Weighted Citation Impact
- 4.34
Funders
- American Society of Nephrology
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science London
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Society for the Promotion of Science
- Core Research for Evolutional Science and Technology